Heron Therapeutics, Inc. (HRTX)
NASDAQ: HRTX · Real-Time Price · USD
0.997
+0.030 (3.09%)
At close: Mar 9, 2026, 4:00 PM EDT
1.000
+0.004 (0.35%)
After-hours: Mar 9, 2026, 7:14 PM EDT

Heron Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Market Capitalization
188238233255297931
Upgrade
Market Cap Growth
-28.18%2.44%-8.79%-14.16%-68.06%-51.60%
Upgrade
Enterprise Value
282331340358333892
Upgrade
Last Close Price
1.001.301.531.702.509.13
Upgrade
PS Ratio
1.211.541.612.012.7610.78
Upgrade
PB Ratio
14.1316.63-6.91-7.5121.9012.00
Upgrade
P/TBV Ratio
14.1417.95--21.9012.00
Upgrade
EV/Sales Ratio
1.822.142.362.823.1010.34
Upgrade
Debt / Equity Ratio
9.819.81-5.28-5.2911.602.06
Upgrade
Net Debt / Equity Ratio
6.566.56-3.52-2.925.350.03
Upgrade
Net Debt / EBITDA Ratio
-419.67-419.67-13.11-1.10-0.44-0.01
Upgrade
Net Debt / FCF Ratio
-3.37-3.37-4.89-1.64-0.49-0.01
Upgrade
Asset Turnover
0.630.630.630.540.390.26
Upgrade
Inventory Turnover
0.580.580.851.482.593.89
Upgrade
Quick Ratio
1.421.421.511.761.662.72
Upgrade
Current Ratio
2.482.482.292.372.503.58
Upgrade
Return on Equity (ROE)
-----399.43%-140.53%
Upgrade
Return on Assets (ROA)
-0.65%-0.65%-3.16%-24.56%-38.01%-41.04%
Upgrade
Return on Capital Employed (ROCE)
-1.60%-1.60%-8.10%-65.10%-100.40%-92.20%
Upgrade
Earnings Yield
-10.75%-8.47%-5.84%-43.34%-61.24%-23.71%
Upgrade
FCF Yield
-14.85%-11.71%-10.41%-23.65%-50.04%-22.18%
Upgrade
Buyback Yield / Dilution
-9.35%-9.35%-10.36%-26.87%-10.57%-8.48%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.